VERA — Vera Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Tesla, Lululemon, energy stocks, Sunnova
Vera Therapeutics falls after kidney drug data from rival Otsuka
U.S. STOCKS ON THE MOVE-Omada Health, Sandisk, Manchester United
U.S. STOCKS ON THE MOVE-Circle, Tesla, Corteva
Otsuka's kidney disease drug shows over 50% reduction in protein in urine (updated)
Vera Therapeutics falls after kidney drug data from rival Otsuka
U.S. STOCKS ON THE MOVE-Natgas companies, UnitedHealth, Cactus
Vera shares skyrocket as kidney disease drug succeeds in late-stage trial (updated)
U.S. STOCKS ON THE MOVE-Lyra Therapeutics, Church & Dwight, Applied Digital
Vera hits nearly 4-month high as kidney disease drug succeeds in late-stage trial
U.S. STOCKS ON THE MOVE-Xilio Therapeutics, Red Rock Resorts, Kymera
Vera shares skyrocket as kidney disease drug succeeds in late-stage trial
Brief: Vera Therapeutics Announces Atacicept Achieved 46% Proteinuria Reduction In ORIGIN Phase 3 Trial In Adults With IgA Nephropathy
U.S. STOCKS ON THE MOVE-Moderna, Blueprint Medicines, Boeing
Vera Therapeutics jumps after kidney disease drug succeeds in late-stage trial
Vera Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Vera Therapeutics Q1 EPS USD -0.81 Vs. IBES Estimate USD -0.74
Brief: Vera Therapeutics FY EPS USD -2.75 Vs. IBES Estimate USD -2.84
Brief: Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)